Skip to main content
Screener/Healthcare/Biotechnology

LXEO — Lexeo Therapeutics, Inc. Common Stock

NASDAQ
$6.34+0.06 (+0.87%)
Small CapUnder $10HealthcareHigh Beta
$2.43
$10.99
$6.27
$6.46
EPS (TTM)$-1.86
P/E Ratio—
Dividend Yield—
Market Cap$543.4M
Volume830K
Prev Close$6.29
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$20.9M$0.06——
Q3 '25$0-$20.3M$-0.33——
Q2 '25$0-$26.1M$-0.60——
Q1 '25$0-$32.7M$-0.99——
Q4 '24$0-$25.9M$-0.78——
Q3 '24$0-$29.5M$-0.89——
Q2 '24$0-$21.2M$-0.64——
Q1 '24$0-$21.7M$-0.77——
Get Your Daily Market Recap